José Luis
Lanciego Pérez
Investigador Senior
Universidad Autónoma de Madrid
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Universidad Autónoma de Madrid (5)
2024
-
Calbindin and Girk2/Aldh1a1 define resilient vs vulnerable dopaminergic neurons in a primate Parkinson’s disease model
npj Parkinson's Disease, Vol. 10, Núm. 1
-
Systemic messenger RNA replacement therapy is effective in a novel clinically relevant model of acute intermittent porphyria developed in non-human primates
Gut
2021
-
Cannabinoid receptor CB2 ablation protects against TAU induced neurodegeneration
Acta Neuropathologica Communications, Vol. 9, Núm. 1
2018
-
Cx3cr1-deficiency exacerbates alpha-synuclein-A53T induced neuroinflammation and neurodegeneration in a mouse model of Parkinson's disease
GLIA, Vol. 66, Núm. 8, pp. 1752-1762
1999
-
Thalamic interaction between the input and the output systems of the basal ganglia
Journal of Chemical Neuroanatomy, Vol. 16, Núm. 3, pp. 187-200